Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 29
- Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)From1 Oct 2018 → 28 Feb 2023Funding: FWO fellowships
- Clin-IC: Medtech solutions for patientsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
- The role of EphA4 in neural repair following ischemic strokeFrom1 Apr 2014 → 16 Mar 2020Funding: BOF - Doctoral projects, FWO fellowships
- JP ND-ALS-CarE : A programme for ALS Care in Europe.From1 Feb 2014 → 31 Jan 2019Funding: FWO research project (including WEAVE projects)
- Identifying COL4A1 and COL4A2 mutations in sporadic cerebral white matter diseaseFrom1 Jan 2014 → 31 Dec 2014Funding: FWO research grant KAN
- The ephrin axon repellent system in amyotrophic lateral sclerosis (ALS).From1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- The ephrin axonal repellent system in Amyotrophic Lateral Sclerosis.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The mechanism of mutant C9orf72 in the pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Lobe Degeneration.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 198
- Heterozygous Deletion of EphrinA5 Does Not Improve Functional Recovery After Experimental Stroke(2019)
Authors: Antina de Boer, Lindsay Poppe, Wim Robberecht, Robin Lemmens
Pages: E101 - E101 - Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies(2019)
Authors: Wim Robberecht, Philip Van Damme, Jelle Demeestere
Pages: 48 - 55 - Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis(2019)
Authors: Philip Van Damme, Matthieu Moisse, Wim Robberecht
Pages: 2298 - + - Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort(2019)
Authors: Philip Van Damme, Wim Robberecht, Matthieu Moisse
- Efficacy and safety of intravenous immunoglobulin IgPro10 in CIDP: Combination of PRIMA and PATH studies(2018)
Authors: Ingemar Merkies, Jean-Marc Leger, Vera Bril, Nan Van Geloven, Hans-Peter Hartung, Richard Lewis, Gen Sobue, John-Philip Lawo, Billie Durn, David Cornblath, et al.
Pages: 264 - 264 - Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis(2018)
Authors: Annelies Nonneman, Nathan Criem, Rik Nuyts, Dietmar Thal, Philip Van Damme, An Zwijsen, Ludo Van Den Bosch, Wim Robberecht
Pages: 26 - 40 - Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice(2018)
Authors: Raheem Fazal, Mathias De Decker, Matthieu Moisse, Wim Robberecht, Ludo Van Den Bosch, Philip Van Damme
- Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis(2018)
Authors: Matthieu Moisse, Wim Robberecht, Philip Van Damme
Pages: 1537 - 1546 - FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins(2018)
Authors: Jolien Steyaert, Joni Vanneste, Philip Van Damme, Wim Robberecht, Patrick Callaerts, Ludo Van Den Bosch
Pages: 1 - 14 - Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1G93A mice(2018)
Authors: Caroline Eykens, Annelies Nonneman, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht
Pages: 1 - 4
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)